Enacting this Bill into law could be a game-changer in that it will expressly authorize CBD in food and as a dietary supplement; however, passage in the Senate is far from a foregone conclusion.
The FDA is poised to be the primary regulatory body governing and setting policy for consumer sales of CBD in the USA. The “wild card” is what, if anything, it will do about products containing hemp extract with CBD.
2020 will be a historic and transformative year for cannabis, particularly for hemp and CBD. Here are my top 5 predictions.
I was recently asked by my friends at Darling Hemp to participate in a video they created to highlight some of the most important issues that the Rule raises.
Considering the large and growing number of hemp and CBD companies doing business in the US right now, the companies that received warning letters might rightly consider themselves unlucky.
As the cannabis industry matures, insurance is becoming a major factor in its growth and normalization. In many respects, the development and availability of insurance products signals a new phase in the industry.
As a cannabis attorney, one of the questions I am asked most frequently is whether hemp and hemp products can be transported across state lines.
Failing to establish testing uniformity almost guarantees mayhem as buyers and growers attempt to create an interstate market for hemp because of the uncertainty a buyer in one state faces when attempting to import hemp from another state.
It is clear is that the FTC has fully entered the CBD regulatory space and we can expect to hear more from it during the coming months.
Jobs in the legal cannabis industry are coming by the hundreds of thousands and there’s no sign of that halting.